richardsoninoq

Contact richardsoninoq

login or register to send private messages to this user

All about richardsoninoq

EMERGENCY CONTRACEPTIVE PILLS - FREE RX, USA PHARMACY
 
 
 
 
 
 
 
 
The differences seen between the desogestrel and levonorgestrel preparations can best be explained by the lower intrinsic androgenicity of 3-keto-desogestrel (active metabolite of desogestrel) than that of levonorgestrel. (1) monophasic desogestrel (150/30), (2) monophasic desogestrel (150/20, containing 20 micrograms of ethinyl estradiol instead of 30 micrograms of ethinyl estradiol, (3) biphasic desogestrel, (4) monophasic levonorgestrel (150/30), and (5) triphasic levonorgestrel. Alesse, sleeping pills an OC manufactured by Wyeth-Ayerst, has the same components. Apolipoprotein B increased in all preparations. Clinical trials involving 755 US women confirmed that Levlite provides high contraceptive efficacy with good cycle control. Two other OCs--Loestrin and Mircette--contain 20 mcg Ethinyl Estradiol, but differ in their Progestin component or dose. Low-density lipoprotein cholesterol slot were increased in monophasic levonorgestrel and clearly decreased in the lowest ethinyl estradiol-containing monophasic desogestrel (150/20) and biphasic desogestrel preparations. A pill containing 20 mcg Ethinyl Estradiol provides women with 33% less Estrogen than a 30-mcg pill.

Headache, reported by 17.3% of study participants, was the most com side effect.. Levlite, manufactured by Berlex Laboratories, contains 20 mcg Ethinyl Estradiol and 100 mcg Levonorgestrel. The antiatherogenic indexes (ratios of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol and apolipoprotein A-I to apolipoprotein B were higher for monophasic desogestrel (150/30) contraceptives and biphasic desogestrel than for comparable levonorgestrel-containing preparations. Berlex introduces new 20 mcg birth control pill.Another low-dose oral contraceptive (OC), Levlite, plan-b has received US Food and Drug Administration approval.

The monophasic desogestrel (150/30) and biphasic desogestrel preparations induced higher high-density lipoprotein cholesterol and apolipoprotein A-I levels than did their levonorgestrel-containing counterparts. The following preparations were studied. The effects of these preparations were assessed on high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A-I, apolipoprotein B, the ratio of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol, and the ratio of apolipoprotein A-I to apolipoprotein B after 3 months of dialogue, and the percentage changes with regard to pretreatment were calculated. Effects of three combined oral safety valve preparations containing